We are testing a new treatment called povetacicept for individuals with autoimmune cytopenias. The study aims to evaluate its safety and effectiveness in managing this condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Autoimmune Cytopenias are a group of disorders where the immune system attacks and destroys blood cells, leading to conditions like warm autoimmune hemolytic anemia, cold agglutinin disease, and immune thrombocytopenia. These conditions can result in low red blood cell or platelet counts, causing symptoms such as fatigue, weakness, and easy bruising.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
